CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | ELISA, FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 488 |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 546 |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 647 |
CD49b (ITGA2) human monoclonal antibody, clone F2H11
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Biotin |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 488 |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | FC, IF |
Reactivities | Human |
Conjugation | Alexa Fluor 647 |
CD49b (ITGA2) human monoclonal antibody, clone B4F12
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Biotin |
CD38 monoclonal antibody (daratumumab biosimilar)
Applications | ELISA, FC |
Reactivities | Human |
Conjugation | Unconjugated |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
Applications | FC, IF |
Reactivities | Human |
Conjugation | Unconjugated |
USD 523.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
Applications | ELISA, FC, IF, IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
USD 523.00
2 Weeks
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
Applications | FC |
Reactivities | Human |
Conjugation | Unconjugated |
Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
Applications | Bl, FC, IP |
Reactivities | Human, Monkey |
Conjugation | Unconjugated |